Literature DB >> 11388889

Molecular cloning, functional characterization and genomic organization of four alternatively spliced isoforms of the human organic cation transporter 1 (hOCT1/SLC22A1).

M Hayer1, H Bönisch, M Brüss.   

Abstract

In this study we report the cloning of four human OCT1 (hOCT1/SLC22A1) isoforms: a long form, hOCT1G/L554, and three shorter forms (hOCT1G/L506, hOCT1G483 and hOCT1G353). All four variants could be identified in the human glioma cell line SK-MG-1, whereas only two isoforms (hOCT1G/L554 and hOCT1G/L506) were found in human liver cDNA. The hOCT1G/L554 represents the full length hOCT1 since the sequence of this clone is more than 99% identical to previously cloned hOCT1 cDNAs. Elucidation of the gene structure of human OCT1 demonstrated that the other isolated isoforms are alternatively spliced variants. The hOCT1 gene consists of 7 exons and 6 introns. When stably expressed in human embryonic kidney (HEK293) cells, only the full length hOCT1 cDNA mediated decynium-22 (D22)-sensitive uptake of tritiated 1-methyl-4-phenylpyridinium ([3H]-MPP+).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11388889     DOI: 10.1017/S0003480099007770

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  21 in total

Review 1.  OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies.

Authors:  Megan Roth; Amanda Obaidat; Bruno Hagenbuch
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

2.  PharmGKB summary: very important pharmacogene information for SLC22A1.

Authors:  Srijib Goswami; Li Gong; Kathleen Giacomini; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2014-06       Impact factor: 2.089

3.  Impact of culture media glucose levels on the intestinal uptake of organic cations.

Authors:  Ana Faria; Rosário Monteiro; Diogo Pestana; Fátima Martel; Victor de Freitas; Nuno Mateus; Conceição Calhau
Journal:  Cytotechnology       Date:  2010-03-06       Impact factor: 2.058

4.  Human organic cation transporter 1 (hOCT1) as a mediator of bendamustine uptake and cytotoxicity in chronic lymphocytic leukemia (CLL) cells.

Authors:  C Arimany-Nardi; A Montraveta; E Lee-Vergés; X S Puente; H Koepsell; E Campo; D Colomer; M Pastor-Anglada
Journal:  Pharmacogenomics J       Date:  2015-01-13       Impact factor: 3.550

Review 5.  Alternative Splicing: Expanding Diversity in Major ABC and SLC Drug Transporters.

Authors:  Ji Eun Park; Gongmi Ryoo; Wooin Lee
Journal:  AAPS J       Date:  2017-10-02       Impact factor: 4.009

6.  Intestinal oxidative state can alter nutrient and drug bioavailability.

Authors:  Ana Faria; Rosário Monteiro; Diogo Pestana; Victor de Freitas; Nuno Mateus; Isabel Azevedo; Conceição Calhau
Journal:  Oxid Med Cell Longev       Date:  2009 Nov-Dec       Impact factor: 6.543

7.  Glioblastoma development in mouse brain: general reduction of OCTs and mislocalization of OCT3 transporter and subsequent uptake of ASP+ substrate to the nuclei.

Authors:  Lilia Y Kucheryavykh; Kimberleve Rolón-Reyes; Yuriy V Kucheryavykh; Serguei Skatchkov; Misty J Eaton; Priscila Sanabria; William D Wessinger; Mikhail Inyushin
Journal:  J Neurosci Neuroeng       Date:  2014-02

8.  Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3.

Authors:  Martina Hayer-Zillgen; Michael Brüss; Heinz Bönisch
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

9.  Hepatocyte nuclear factor 1 regulates the expression of the organic cation transporter 1 via binding to an evolutionary conserved region in intron 1 of the OCT1 gene.

Authors:  Valerie P O'Brien; Kristin Bokelmann; Jacqueline Ramírez; Karoline Jobst; Mark J Ratain; Jürgen Brockmöller; Mladen V Tzvetkov
Journal:  J Pharmacol Exp Ther       Date:  2013-08-06       Impact factor: 4.030

Review 10.  Role of SLC22A1 polymorphic variants in drug disposition, therapeutic responses, and drug-drug interactions.

Authors:  C Arimany-Nardi; H Koepsell; M Pastor-Anglada
Journal:  Pharmacogenomics J       Date:  2015-11-03       Impact factor: 3.550

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.